Martin Everett

2.6k citations

28 papers · 2.0k indexed · h-index 19

Impact in

Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Endocrinology top 2%

Papers in ⓘ

Molecular Medicine 16
- Antibiotic Resistance in Bacteria 16
Applied Microbiology and Biotechnology 2

Co-authors: Yossef Av‐Gay (1 shared paper)Laura J. V. Piddock (4 shared papers)Yongfeng Jin (1 shared paper)Vito Ricci (1 shared paper)David T. Davies (7 shared papers)Tom Solomon (1 shared paper)Ha Vinh (1 shared paper)Christopher M. Parry (1 shared paper)
Journals: Antimicrobial Agents and Chemotherapy (7 papers)Microbiology (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Clinical Infectious Diseases (1 paper)Scientific Reports (1 paper)
Partner nations: United Kingdom United States Singapore

In The Last Decade

Martin Everett

28 papers receiving 1.9k citations

Peers

Countries citing papers authored by Martin Everett

Since Specialization

Citations

This map shows the geographic impact of Martin Everett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Everett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Everett more than expected).

Fields of papers citing papers by Martin Everett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Everett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Everett. The network helps show where Martin Everett may publish in the future.

Co-authors

The 25 scholars most cited alongside Martin Everett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martin Everett Line = papers co-authored together Martin Everett links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The eukaryotic-like Ser/Thr protein kinases of Mycobacterium tuberculosis Trends in Microbiology ·Yossef Av‐Gay, Martin Everett	2000	311
2	Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals Antimicrobial Agents and Chemotherapy ·Martin Everett, Yongfeng Jin, Vito Ricci, Laura J. V. Piddock	1996	302
3	Quinolone‐ResistantSalmonella typhiin Viet Nam: Molecular Basis of Resistance and Clinical Response to Treatment Clinical Infectious Diseases ·John Wain, Nguyen Thi Tuyet Hoa, Nguyen Tran Chinh, Ha Vinh, Martin Everett, To S. Diep, Nicholas Day, Tom Solomon, Nicholas J. White, Laura J. V. Piddock, Christopher M. Parry	1997	240
4	Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement The Lancet Infectious Diseases ·Ian Chopra, Christopher J. Schofield, Martin Everett, Alex J. O’Neill, Keith Miller, Mark H. Wilcox, Jean‐Marie Frère, Michael J. Dawson, Lloyd G. Czaplewski, U. Urleb, Patrice Courvalin	2008	197
5	Galactan Biosynthesis in Mycobacterium tuberculosis Journal of Biological Chemistry ·Laurent Kremer, Lynn G. Dover, Caroline Morehouse, Paul Hitchin, Martin Everett, Howard R. Morris, Ann Dell, Patrick J. Brennan, Michael McNeil, Christopher Flaherty, Ken Duncan, Gurdyal S. Besra	2001	125
6	Cloning and Characterization of Arylamine N -Acetyltransferase Genes from Mycobacterium smegmatis and Mycobacterium tuberculosis : Increased Expression Results in Isoniazid Resistance Journal of Bacteriology ·Mark A. Payton, Roy Auty, Rupika Delgoda, Martin Everett, Edith Sim	1999	107
7	Characterization of a Mycobacterium tuberculosis H37Rv transposon library reveals insertions in 351 ORFs and mutants with altered virulence b bThe precise locations of all of the insertions examined in this study can be found as supplementary data in Microbiology Online (http://mic.sgmjournals.org). Microbiology ·Ruth A. McAdam, Selwyn Quan, Debbie A. Smith, Stoyan Bardarov, Joanna Betts, Fiona C. Cook, Elizabeth U. Hooker, Alan P. Lewis, Peter Woollard, Martin Everett, Pauline T. Lukey, Gregory J. Bancroft, William R. Jacobs, Ken Duncan	2002	106
8	Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae Antimicrobial Agents and Chemotherapy ·Martin Everett, Nicolas Sprynski, Alicia Coelho, Jérôme Castandet, Maëlle Bayet, Juliette Bougnon, Clarisse Lozano, David T. Davies, Simon Leiris, Magdalena Zalacaín, Ian Morrissey, Sophie Magnet, Kirsty Holden, Peter Warn, Filomena De Luca, Jean‐Denis Docquier, Marc Lemonnier	2018	84
9	Expression, characterization and subcellular localization of the Mycobacterium tuberculosis PPE gene Rv1917c Tuberculosis ·Samantha L. Sampson, Pauline T. Lukey, Robin M. Warren, Paul D. van Helden, M. Richardson, Martin Everett	2001	83
10	Pseudomonas aeruginosa elastase (LasB) as a therapeutic target Drug Discovery Today ·Martin Everett, David T. Davies	2021	60
11	Inactivation of polyketide synthase and related genes results in the loss of complex lipids in Mycobacterium tuberculosis H37Rv Letters in Applied Microbiology ·Simon J. Waddell, Gavin A.C. Chung, Kevin J. Gibson, Martin Everett, David E. Minnikin, Gurdyal S. Besra, Philip D. Butcher	2005	39
12	Inhibitors of neutrophil recruitment identified using transgenic zebrafish to screen a natural product library Disease Models & Mechanisms ·Xingang Wang, Anne L. Robertson, Jingyu Li, Ruth Jinfen Chai, Haishan Wang, Pranvera Sadiku, Nikolay V. Ogryzko, Martin Everett, Yoganathan Kanagasundaram, Hongbo R. Luo, Stephen A. Renshaw, Philip W. Ingham	2013	39
13	Pseudomonas aeruginosa Elastase Contributes to the Establishment of Chronic Lung Colonization and Modulates the Immune Response in a Murine Model Frontiers in Microbiology ·Cristina Cigana, Jérôme Castandet, Nicolas Sprynski, Medede Melessike, Lilha Beyria, Serena Ranucci, Beatriz Alcalá-Franco, Alice S. Rossi, Alessandra Bragonzi, Magdalena Zalacaín, Martin Everett	2021	29
14	Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria Accounts of Chemical Research ·David T. Davies, Martin Everett	2021	27
15	Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive Enterobacterales Antimicrobial Agents and Chemotherapy ·Magdalena Zalacaín, Clarisse Lozano, Agustina Llanos, Nicolas Sprynski, Thomas Valmont, Cyntia De Piano, David T. Davies, Simon Leiris, Carole A. Sable, Adeline Ledoux, Ian Morrissey, Marc Lemonnier, Martin Everett	2021	25
16	Interaction of kendomycin and semi-synthetic analogues with the anti-apoptotic protein Bcl-xl Bioorganic & Medicinal Chemistry Letters ·Christian O. Janßen, Stephanie Lim, Ee Peng Lo, Kah Fei Wan, Victor C. Yu, May Ann Lee, Siew Bee Ng, Martin Everett, Antony D. Buss, David P. Lane, Rustum S. Boyce	2008	21
17	cDNA–RNA subtractive hybridization reveals increased expression of mycocerosic acid synthase in intracellular Mycobacterium bovis BCG Microbiology ·Mingshi Li, Irene M. Monahan, Simon J. Waddell, Joseph A. Mangan, Steve L. Martin, Martin Everett, Philip D. Butcher	2001	20
18	Evaluation of N-(phenylmethyl)-4-[5-(phenylmethyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-4-yl]benzamide inhibitors of Mycobacterium tuberculosis growth Bioorganic & Medicinal Chemistry Letters ·Michael D. Wall, Michael Oshin, Gavin A.C. Chung, Tony Parkhouse, Andrea Gore, Esperanza Herreros, Brian J. Cox, Ken Duncan, Brian Evans, Martin Everett, Alfonso Mendoza	2007	19
19	Role ofgyrAmutation and loss of OprF in the multiple antibiotic resistance phenotype ofPseudomonas aeruginosaG49 FEMS Microbiology Letters ·Lilian Pumbwe, Martin Everett, Robert E. W. Hancock, Laura J. V. Piddock	1996	18
20	Novel Ciprofloxacin-Resistant, Nalidixic Acid-Susceptible Mutant of Staphylococcus aureus Antimicrobial Agents and Chemotherapy ·Laura J. V. Piddock, Yu Jin, Mark Webber, Martin Everett	2002	18

About Martin Everett

Martin Everett is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Infectious Diseases, Microbiology and Pharmacology, having authored 28 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (16 papers), Tuberculosis Research and Epidemiology (11 papers), Bacterial biofilms and quorum sensing (8 papers), Mycobacterium research and diagnosis (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Bacterial Genetics and Biotechnology (4 papers), Antimicrobial Peptides and Activities (4 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Molecular Medicine (741 citations), Endocrinology (242 citations), Applied Microbiology and Biotechnology (79 citations), Infectious Diseases (720 citations) and Pharmacology (329 citations). Martin Everett has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include Yossef Av‐Gay, Laura J. V. Piddock, Yongfeng Jin, Vito Ricci, David T. Davies, Tom Solomon, Ha Vinh, Christopher M. Parry, Nguyen Tran Chinh and Nicholas J. White. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Microbiology, Bioorganic & Medicinal Chemistry Letters, Clinical Infectious Diseases and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact